Detectable cTnT levels as measured by a highly sensitive assay were detectable in the majority of SLE patients in this cohort and in nearly 90% of SLE patients with carotid plaques, independent of traditional risk factors. The gene discussed is TNNT2; the disease is systemic lupus erythematosus.